Guangzhou Wondfo Biotech Co Ltd 300482.SZ

Last Updated: May 15, 12:00 AM·SZSE

Guangzhou Wondfo Biotech Co Ltd

Guangzhou Wondfo Biotech Co Ltd. Stock Analysis 300482.SZ

China Health Care Small Cap
Guangzhou Wondfo Biotech Co., Ltd. engages in the manufacture and sale of biochemical reagents, medical products and diagnostic test kits. The company is headquartered in Guangzhou, Guangdong and currently employs 2,443 full-time employees. The company went IPO on 2015-06-30. The firm's business covers clinical testing, critical care, chronic disease management, primary healthcare, disaster relief, on-site law enforcement, and family/personal health management. The firm's products include those for cardiovascular diseases, inflammation, tumors, infectious diseases, toxicology (drug abuse), and prenatal and postnatal care.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.